Results 11 to 20 of about 93,175 (205)

Development of an EBOV MiniG plus system as an advanced tool for anti-Ebola virus drug screening

Heliyon, 2023
The incidence of zoonotic diseases, such as coronavirus disease 2019 and Ebola virus disease, is increasing worldwide. However, drug and vaccine development for zoonotic diseases has been hampered because the experiments involving live viruses are ...
Chi-Ju Hsu, Cheng-Hsiu Chen, Wen-Ting Chen, Ping-Cheng Liu, Tein-Yao Chang, Meng-He Lin, Cheng-Cheung Chen, Hsing-Yu Chen, Chih-Heng Huang, Yun-Hsiang Cheng, Jun-Ren Sun   +10 more
doaj   +1 more source

Care and COVID 19: Lessons for liberals and neoliberals

Child &Family Social Work, EarlyView., 2023
Abstract Within the liberal political traditions, care is regarded as a private matter, a problem of ethics rather than justice. Social justice is framed as an issue of economics (re/distribution), culture (recognition) and/or politics (representation).
Kathleen Lynch
wiley   +1 more source

Virus specific antibody - based remedies for the urgent prevention and treatment of Ebola virus disease [PDF]

Терапевтический архив, 2019
The Ebola virus (member of Ebolavirus genus Filoviridae family) is the etiologic agent of extremely hazard human disease with high mortality rates (up to 90%). The most important components of spectrum of therapeutics for special prophylactic and current
T E Sizikova, V N Lebedev, S V Borisevich   +2 more
doaj   +1 more source

The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps

Vaccines, 2022
The Ebola virus disease outbreak that occurred in Western Africa from 2013–2016, and subsequent smaller but increasingly frequent outbreaks of Ebola virus disease in recent years, spurred an unprecedented effort to develop and deploy effective vaccines ...
Ian Crozier, Kyla A. Britson, Daniel N. Wolfe, John D. Klena, Lisa E. Hensley, John S. Lee, Larry A. Wolfraim, Kimberly L. Taylor, Elizabeth S. Higgs, Joel M. Montgomery, Karen A. Martins   +10 more
doaj   +1 more source

A comparative computational genomics of Ebola Virus Disease strains: In-silico Insight for Ebola control

Informatics in Medicine Unlocked, 2018
Ebola Virus Disease (EVD), is a national epidemic in Countries affected. It is also a potential global public health pandemic. The menace of the disease outbreak among West and Central African nations, in recent years, has resulted in the death of many ...
Olugbenga Oluwagbemi, Olaitan Awe
doaj   +1 more source

Recommendations for dealing with waste contaminated with Ebola virus: a Hazard Analysis of Critical Control Points approach [PDF]

, 2016
Objective To assess, within communities experiencing Ebola virus outbreaks, the risks associated with the disposal of human waste and to generate recommendations for mitigating such risks.
Ahmed A Mohamedani, Benedict M Mutua, Brainard, Chepurnov, Diana J Bell, Edward Muchiri, Guy Howard, Harvey Minnigh, Iain Lake, Joseph Matofari, Julii Brainard, Julius M Ndambuki, Katherine Pond, Kelly L Edmunds, Lutendo S Mudau, Maggie Montgomery, Mark D Sobsey, Mark Zeitoun, Mike van der Es, Paul R Hunter, Peter Maes, Roger Few, Samir Dervisevic, Samira Abd Elrahman, Sarah Morter, Tsimbiri P Fedha   +25 more
core   +2 more sources

Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data

The Lancet Global Health, 2016
Background: Ebola virus has been detected in semen of Ebola virus disease survivors after recovery. Liberia's Men's Health Screening Program (MHSP) offers Ebola virus disease survivors semen testing for Ebola virus.
Moses J Soka, MD, Dr. Mary J Choi, MD, April Baller, MRCGP, Stephen White, MSc, Emerson Rogers, BSc, Lawrence J Purpura, MD, Nuha Mahmoud, MD, Christine Wasunna, PhD, Moses Massaquoi, MD, Neetu Abad, PhD, Jomah Kollie, RN, Straker Dweh, Philip K Bemah, MD, Athalia Christie, MIA, Victor Ladele, MBBS, Oneychachi C Subah, BSc, Satish Pillai, MD, Margaret Mugisha, MPH, Jonathan Kpaka, BSc, Stephen Kowalewski, BS, Emilio German, MSHSA, Mark Stenger, MA, Stuart Nichol, PhD, Ute Ströher, PhD, Kristin E Vanderende, PhD, Shauna Mettee Zarecki, MSN, Hugh Henry W Green, MPH, Jeffrey A Bailey, MD, Pierre Rollin, MD, Barbara Marston, MD, Tolbert G Nyenswah, MPH, Alex Gasasira, MBChB, Barbara Knust, DVM, Desmond Williams, MD   +33 more
doaj   +1 more source

Impact of the Ebola virus disease outbreak (2014–2016) on tuberculosis surveillance activities by Guinea’s National Tuberculosis Control Program: a time series analysis

BMC Public Health, 2020
Background Most countries in Subsaharan Africa have well-established National Tuberculosis Control Programs with relatively stable routine performances. However, major epidemiological events may result in significant disruptions. In March 2014, the World
Aboubacar Sidiki Magassouba, Boubacar Djelo Diallo, Lansana Mady Camara, Kadiatou Sow, Souleymane Camara, Boubacar Bah, Alpha Oumar Barry, Thierno Hassane Diallo, Aboubacar Camara, Adama Marie Bangoura, Oumou Younoussa Sow   +10 more
doaj   +1 more source

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans

Frontiers in Immunology, 2023
IntroductionIn the absence of clinical efficacy data, vaccine protective effect can be extrapolated from animals to humans, using an immunological biomarker in humans that correlates with protection in animals, in a statistical approach called ...
Chelsea McLean, Karin Dijkman, Auguste Gaddah, Babajide Keshinro, Michael Katwere, Macaya Douoguih, Cynthia Robinson, Laura Solforosi, Dominika Czapska-Casey, Liesbeth Dekking, Yvonne Wollmann, Ariane Volkmann, Maria Grazia Pau, Benoit Callendret, Jerry Sadoff, Hanneke Schuitemaker, Roland Zahn, Kerstin Luhn, Jenny Hendriks, Ramon Roozendaal   +19 more
doaj   +1 more source

Deaths, late deaths, and role of infecting dose in Ebola virus disease in Sierra Leone: retrospective cohort study. [PDF]

, 2016
OBJECTIVES:  To assess the frequency of fatal recrudescence from Ebola virus disease after discharge from treatment centres, and explore the influence of infecting dose on case fatality rates. DESIGN:  Retrospective cohort study.
Bangura, Mohamed S, Bower, Hilary, Checchi, Francesco, Glynn, Judith R, Johnson, Sembia, Kamara, Osman, Oza, Shefali, Smout, Elizabeth, Turay, Cecilia   +8 more
core   +1 more source